14 Best 52-Week High Stocks To Buy According to Analysts

7. Royalty Pharma plc (NASDAQ:RPRX)

52 Week Range: $24.05 – $31.66

Current Share Price: $30.03

Stock Upside Potential: 45.33%

Number of Hedge Fund Holders: 33

Royalty Pharma plc (NASDAQ:RPRX) is a healthcare company that operates as a buyer of biopharmaceutical royalties and a financier of innovations in the biopharmaceutical industry. It is also involved in identifying, evaluating, and acquiring royalties on various bio-pharmaceutical therapies. After rallying by about 5% in 2024, the stock has started 2025 on a roll, rallying by about 17%.

According to analysts, amid the strong moves in the market, Royalty Pharma plc (NASDAQ:RPRX) is one of the best 52-week high stocks to buy. That’s partly due to the key achievements clocked in 2024, including about $2.8 billion in portfolio receipts. The company also achieved a 13% growth in royalty receipts. A confirmation that the company is on course to acquire its external manager, RP Management, for $1.1 billion, saving it more than $1.6 billion in ten years, should allow it to generate more shareholder value.

A resilient evaluation and acquisition of royalties has allowed Royalty Pharma plc (NASDAQ:RPRX) to generate significant cash flow to return value to shareholders. The stock continues to reward investors with a 2.93% dividend yield, having increased its quarterly payout by 5% to $0.22 a share.